ClinChoice
↗Fort Washington, USA / Shanghai, China
ClinChoice is a leading global, full-service Contract Research Organization (CRO) providing clinical development and functional solutions to pharmaceutical, biotechnology, medical device, and consumer health companies. Founded in 1995, the company offers a wide range of services including clinical operations, biostatistics, data management, regulatory affairs, medical writing, and pharmacovigilance.
With over 4,000 professionals operating in more than 30 countries across the Americas, Europe, and Asia-Pacific, ClinChoice supports the entire drug development lifecycle. The company is known for its deep regulatory expertise and ability to manage complex, multi-regional clinical trials, having completed over 3,000 studies globally.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1995
Ownership:private
Status:operating
FUNDING
Stage:Series E
Total Raised:$212M
Investors:Goldman Sachs, Lilly Asia Ventures, Draper Fisher Jurvetson, Legend Capital
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, Biologics, Cell therapy, Vaccines
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:CSI Medical Research
Key Partnerships:Monash University (Strategic partnership for early-phase clinical trials), Medidata (Long-standing partnership for clinical trial technology)
COMPETITION
Position:Leader
Competitors:Parexel, TFS, Siro Clinpharm, IQVIA
LEADERSHIP
Key Executives:
Kevin Xu - Chairman and CEO
Tiepu Liu - President, Head of Biometrics
Scientific Founders:Xin Ke, John D. Balian
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ClinChoice and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ClinChoice. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.